scholarly journals Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial

Endocrine ◽  
2017 ◽  
Vol 57 (1) ◽  
pp. 156-165 ◽  
Author(s):  
S. Petersenn ◽  
L. R. Salgado ◽  
J. Schopohl ◽  
L. Portocarrero-Ortiz ◽  
G. Arnaldi ◽  
...  
Keyword(s):  
Cushing’S Disease ◽  
Term Treatment ◽  
Phase Iii ◽  
Cushing's Disease ◽  
Extension Study ◽  
Open Label ◽  
Phase Iii Trial ◽  
Long Term Treatment ◽  
Open Label Extension

Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study

2019 ◽  
Vol 7 (8) ◽  
pp. 657-664 ◽  
Author(s):  
Ganesh Raghu ◽  
Bernt van den Blink ◽  
Mark J Hamblin ◽  
A Whitney Brown ◽  
Jeffrey A Golden ◽  
...  
Keyword(s):  
Idiopathic Pulmonary Fibrosis ◽  
Pulmonary Fibrosis ◽  
Term Treatment ◽  
Extension Study ◽  
Open Label ◽  
Long Term Treatment ◽  
Open Label Extension

Long-Term Treatment of Cushing’s Disease with Pasireotide (SOM230): Results from a Phase II Extension Study.

2010 ◽  
pp. P1-274-P1-274 ◽  
Author(s):  
M Boscaro ◽  
Y Zhang ◽  
K Sen ◽  
M Maldonado ◽  
U Schoenherr ◽  
...  
Keyword(s):  
Phase Ii ◽  
Cushing’S Disease ◽  
Term Treatment ◽  
Cushing's Disease ◽  
Extension Study ◽  
Long Term Treatment

scholarly journals Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study

2016 ◽  
Vol 234 (2) ◽  
pp. 199-209 ◽  
Author(s):  
Suresh Durgam ◽  
William M. Greenberg ◽  
Dayong Li ◽  
Kaifeng Lu ◽  
Istvan Laszlovszky ◽  
...  
Keyword(s):  
Term Treatment ◽  
Extension Study ◽  
Open Label ◽  
Long Term Treatment ◽  
Open Label Extension
Sign in / Sign up

Export Citation Format

Share Document